| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.13B | 12.06B | 11.41B | 10.79B | 11.34B |
| Gross Profit | 6.08B | 6.46B | 6.02B | 5.43B | 5.85B |
| EBITDA | 8.52B | 8.63B | 8.08B | 7.55B | 7.96B |
| Net Income | 3.08B | 3.11B | 3.16B | 2.95B | 2.93B |
Balance Sheet | |||||
| Total Assets | 118.45B | 118.50B | 118.54B | 121.00B | 114.83B |
| Cash, Cash Equivalents and Short-Term Investments | 28.00M | 30.00M | 21.00M | 325.00M | 34.00M |
| Total Debt | 50.56B | 50.86B | 50.21B | 51.21B | 46.63B |
| Total Liabilities | 68.36B | 69.21B | 69.56B | 71.67B | 66.44B |
| Stockholders Equity | 49.31B | 49.29B | 48.98B | 49.33B | 48.39B |
Cash Flow | |||||
| Free Cash Flow | 3.39B | 2.38B | 3.79B | -993.00M | 1.36B |
| Operating Cash Flow | 7.13B | 6.38B | 8.07B | 4.77B | 6.19B |
| Investing Cash Flow | -3.78B | -3.99B | -4.38B | -6.08B | -5.03B |
| Financing Cash Flow | -3.31B | -2.38B | -4.04B | 1.61B | -1.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$190.49B | 16.48 | 9.82% | 4.54% | -3.24% | -10.85% | |
70 Outperform | HK$71.19B | 12.01 | 12.60% | 4.30% | 1.89% | -1.58% | |
68 Neutral | HK$102.82B | 6.06 | 12.76% | 5.89% | -3.11% | -5.45% | |
68 Neutral | HK$138.63B | 18.85 | 6.94% | 5.15% | -16.10% | 1.91% | |
66 Neutral | HK$56.73B | 18.09 | 5.56% | 5.08% | 0.56% | 1.22% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$135.47B | 23.00 | 9.73% | 4.94% | -2.07% | -0.42% |